DE69317444T2 - Antivirale topische pharmazeutische zusammensetzungen - Google Patents

Antivirale topische pharmazeutische zusammensetzungen

Info

Publication number
DE69317444T2
DE69317444T2 DE69317444T DE69317444T DE69317444T2 DE 69317444 T2 DE69317444 T2 DE 69317444T2 DE 69317444 T DE69317444 T DE 69317444T DE 69317444 T DE69317444 T DE 69317444T DE 69317444 T2 DE69317444 T2 DE 69317444T2
Authority
DE
Germany
Prior art keywords
topical pharmaceutical
pharmaceutical compositions
antiviral
antiviral topical
dispersed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69317444T
Other languages
English (en)
Other versions
DE69317444D1 (de
Inventor
Amnon Sintov
Rina Uzan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Padagis Israel Pharmaceuticals Ltd
Original Assignee
Agis Industries 1983 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agis Industries 1983 Ltd filed Critical Agis Industries 1983 Ltd
Application granted granted Critical
Publication of DE69317444D1 publication Critical patent/DE69317444D1/de
Publication of DE69317444T2 publication Critical patent/DE69317444T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69317444T 1992-12-30 1993-12-29 Antivirale topische pharmazeutische zusammensetzungen Expired - Fee Related DE69317444T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL10428392A IL104283A (en) 1992-12-30 1992-12-30 Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
PCT/GB1993/002664 WO1994015614A1 (en) 1992-12-30 1993-12-29 Antiviral topical pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DE69317444D1 DE69317444D1 (de) 1998-04-16
DE69317444T2 true DE69317444T2 (de) 1998-08-27

Family

ID=11064372

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69317444T Expired - Fee Related DE69317444T2 (de) 1992-12-30 1993-12-29 Antivirale topische pharmazeutische zusammensetzungen

Country Status (9)

Country Link
US (1) US5585379A (de)
EP (1) EP0677126B1 (de)
JP (1) JPH08505850A (de)
AT (1) ATE163980T1 (de)
AU (1) AU671704B2 (de)
CA (1) CA2152907C (de)
DE (1) DE69317444T2 (de)
IL (1) IL104283A (de)
WO (1) WO1994015614A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE211462T1 (de) * 1992-10-30 2002-01-15 Searle & Co N-substituierte hydroxyethylaminosulfamidsäure- derivate verwendbar als inhibitoren retroviraler proteasen
IL110380A0 (en) * 1994-07-20 1994-10-21 Agis Ind 1983 Ltd Antiviral topical pharmaceutical compositions
GB9417249D0 (en) * 1994-08-26 1994-10-19 Wellcome Found A novel salt
AU4282096A (en) * 1994-11-15 1996-06-06 Osmotics Corporation Skin care compositions and methods
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
TW438585B (en) * 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions
EP0787490A1 (de) * 1996-01-31 1997-08-06 Agis Industries (1983) Ltd Topische Zusammensetzung zur Prevention und Behandlung der mit Herpesvirus assoziierten Verletzungen und Wunde
WO1997034607A1 (en) * 1996-03-20 1997-09-25 Glaxo Group Limited Topical formulations of aciclovir
US5863560A (en) * 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
DE69739583D1 (de) * 1996-11-14 2009-10-29 Lipomedica Ehf Topische zusammensetzungen enthaltend als therapeutisch aktiven wirkstoff ein monoglycerid zur behandlung von schleimhautinfektionen
US6368625B1 (en) 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
US6107303A (en) * 1999-03-15 2000-08-22 Demarco; Charlene C. Treatment of Epstein Barr infection
US7129274B1 (en) 1999-11-05 2006-10-31 Emisphere Technologies Inc. Phenoxy carboxylic acid compounds and compositions for delivering active agents
US7279597B1 (en) 1999-11-05 2007-10-09 Emisphere Technologies, Inc. Phenyl amine carboxylic acid compounds and compositions for delivering active agents
IL149336A0 (en) * 1999-11-05 2002-11-10 Emisphere Tech Inc Phenyl amine carboxylic acid compounds and compositions for delivering active agents
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
DE10219597A1 (de) * 2002-05-02 2003-11-20 Wella Ag Wasserfreie Haarstylinggele
CA2562190C (en) * 2004-04-05 2012-08-21 Laboratorios Liomont, S.A. De C.V. Novel antiviral pharmaceutical composition
MXPA06013295A (es) * 2004-05-19 2007-02-22 Emisphere Tech Inc Formulaciones de aciclovir.
ITMI20051417A1 (it) * 2005-07-22 2007-01-23 Mipharm S P A Formulazione topica in forma di gel contenente come ingredienti attivi ciclovit e lidocaina
ITMI20071724A1 (it) * 2007-09-05 2009-03-06 Fidia Farmaceutici Formulazioni topiche antivirali in forma di gel bioadesivo
US8236768B2 (en) 2008-10-03 2012-08-07 3B Pharmaceuticals, Inc. Topical antiviral formulations
US20110117182A1 (en) * 2009-07-30 2011-05-19 Allergan, Inc. Combination of dapsone with other anti-acne agents
WO2011035120A2 (en) * 2009-09-17 2011-03-24 Gk Ventures, L.L.C. Therapeutic composition to treat lesions caused by herpes simplex virus
EP3443964A1 (de) 2011-11-23 2019-02-20 3B Pharmaceuticals, Inc. Antivirale formulierungen
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US10231924B2 (en) 2016-03-23 2019-03-19 Cmpd Licensing, Llc Compounded topical composition and method
CN111821254B (zh) * 2019-04-18 2021-10-15 华东师范大学 一种抗病毒水凝胶及其制备方法和应用
CN114302707A (zh) * 2019-06-14 2022-04-08 普洛拉治疗公司 局部阿昔洛韦制剂及其用途
CN114010590B (zh) * 2021-11-24 2023-12-01 华东师范大学 一种核苷类抗病毒药物凝胶及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
GB8320203D0 (en) * 1983-07-27 1983-09-01 Horrobin D F Anti-viral compositions
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
JP2831030B2 (ja) * 1989-05-12 1998-12-02 学校法人城西大学 ３’‐アジド‐３’デオキシチミジンを有効成分とする経皮投与製剤用組成物

Also Published As

Publication number Publication date
IL104283A (en) 1996-12-05
WO1994015614A1 (en) 1994-07-21
ATE163980T1 (de) 1998-03-15
CA2152907C (en) 2004-03-30
CA2152907A1 (en) 1994-07-21
JPH08505850A (ja) 1996-06-25
AU671704B2 (en) 1996-09-05
EP0677126B1 (de) 1998-03-11
DE69317444D1 (de) 1998-04-16
IL104283A0 (en) 1993-05-13
US5585379A (en) 1996-12-17
AU5711894A (en) 1994-08-15
EP0677126A1 (de) 1995-10-18

Similar Documents

Publication Publication Date Title
DE69317444T2 (de) Antivirale topische pharmazeutische zusammensetzungen
YU22794A (sh) Veterinarska kompozicija
NZ295211A (en) Topical aqueous gel containing a water-soluble cellulose derivative, propylene glycol & drug(s) for haemorrhoids
ATE51342T1 (de) Mittel und vorrichtung zur steuerung der transdermalen penetration topischer und systematischer wirkstoffe.
NO992638L (no) Gelformulering for topisk legemiddellevering
TR200101262T2 (tr) Uzun süreli salınımlı ranolazin formülasyonları
CA2076465A1 (en) Cell binding agent conjugates of analogues and derivatives of cc-1065
CA2081068A1 (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
FR2598320B1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
WO1999012545A3 (en) Medicaments containing acyclovir
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
CA2305764A1 (en) Bile acid salts of metals with physiological action and the use thereof in therapy
ES2047451B1 (es) Procedimiento para la preparacion de una composicion farmaceutica oral estable.
CA2161683A1 (en) Veterinary composition containing a proton pump inhibitor
MY106605A (en) Compositions for the treatment of leishmaniasis
AR010457A1 (es) Composicion farmaceutica de acido picolinico o un derivado del mismo y metodos de tratamiento de enfermedades

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee